- DOJ reaches largest-ever federal government settlement over auto loan discrimination
- U.S. Navy to start giving gay couples marriage benefits in Japan
- Sen. Harry Reid goes to hospital as a precaution
- Fla.’s Trey Radel exits rehab, ‘excited’ to resume congressional role
- U.S. nuclear general boozed it up, chased ‘hot women’ in Russia: report
- 45 Calif. students at one school test positive for tuberculosis exposure
- Rob Ford on women: Give them cash ‘and they are happy’
- Ku Klux Klan group holds recruitment meeting in Maryland
- Airport assassination: Mayor, 3 others killed at Manila airport
- Tea party-type lawmakers take mysterious, off-books trip to Mideast
By John McAfee
Independent voices from the The Washington Times Communities
Topic - Marc Laforce
Health workers will use a new vaccine to protect 20 million people in three West African countries against meningitis, a disease that kills thousands each year on the continent and leaves others brain damaged, officials said Monday.
"This is a success story and it represents the development of a product that has taken 10 years to develop and we have been so excited because we'll be introducing the new vaccine for sub-Saharan Africa," said Dr. Marc Laforce, head of the Meningitis Vaccine Project.